论文标题
个性化定价中的公平,福利和公平性
Fairness, Welfare, and Equity in Personalized Pricing
论文作者
论文摘要
我们根据客户功能研究个性化定价中的公平,福利和公平考虑因素的相互作用。卖方越来越能够基于对协变量条件的需求的预测建模来进行价格个性化:设定定制利率,有针对性的消费品折扣以及稀缺资源的个性化补贴,具有疫苗和床网等积极外部性。这些不同的应用领域可能会导致对公平,福利和公平目标的不同关注:消费者的价格负担,价格嫉妒,企业收入,获得良好的,平等的访问和分配后果时,当问题上的好处进一步影响下游兴趣的下游成果时。我们进行全面的文献综述,以解除这些不同的规范考虑因素,并提出具有数学定义的不同目标的分类法。我们专注于观察指标,这些指标不假定访问基本的估值分布,该分布由于二进制反馈而无法观察到,或者由于对解释揭示的偏好的压倒性行为问题而导致的不确定。在设定具有积极收益的商品的个性化定价的情况下,我们讨论了价格优化如何通过实现“三重底线”来提供明显的收益:个性化的定价可以扩大访问权限,这反过来又可能导致由于多种效用而导致福利的增长,并提高收入或预算利用率。我们从经验上证明了在两种环境中个性化定价的潜在好处:选择性疫苗的定价补贴以及个性化利率对微累力下游结果的影响。
We study the interplay of fairness, welfare, and equity considerations in personalized pricing based on customer features. Sellers are increasingly able to conduct price personalization based on predictive modeling of demand conditional on covariates: setting customized interest rates, targeted discounts of consumer goods, and personalized subsidies of scarce resources with positive externalities like vaccines and bed nets. These different application areas may lead to different concerns around fairness, welfare, and equity on different objectives: price burdens on consumers, price envy, firm revenue, access to a good, equal access, and distributional consequences when the good in question further impacts downstream outcomes of interest. We conduct a comprehensive literature review in order to disentangle these different normative considerations and propose a taxonomy of different objectives with mathematical definitions. We focus on observational metrics that do not assume access to an underlying valuation distribution which is either unobserved due to binary feedback or ill-defined due to overriding behavioral concerns regarding interpreting revealed preferences. In the setting of personalized pricing for the provision of goods with positive benefits, we discuss how price optimization may provide unambiguous benefit by achieving a "triple bottom line": personalized pricing enables expanding access, which in turn may lead to gains in welfare due to heterogeneous utility, and improve revenue or budget utilization. We empirically demonstrate the potential benefits of personalized pricing in two settings: pricing subsidies for an elective vaccine, and the effects of personalized interest rates on downstream outcomes in microcredit.